المؤلفون: Bart Neyns, Christian U. Blank, Michal Lotem, Mark R. Middleton, J.-J. Grob, Melanie A. Leiby, Antoni Ribas, C. Robert, Jacob Schachter, Céleste Lebbé, Euan Walpole, Matteo S. Carlino, Neil Steven, Nageatte Ibrahim, Peter Mohr, A. Arance, Paul Lorigan, Mario Sznol, Erin Jensen, Georgina V. Long, Laurent Mortier

المساهمون: Faculty of Law and Criminology, Medical Oncology, Clinical sciences, Laboratory of Molecular and Medical Oncology, Faculty of Arts and Philosophy

المصدر: Long, G V, Arance, A, Mortier, L, Lorigan, P, Blank, C, Mohr, P, Schachter, J, Grob, J-J, Lotem, M, Middleton, M R, Neyns, B, Steven, N, Ribas, A, Walpole, E, Carlino, M S, Lebbe, C, Sznol, M, Jensen, E, Leiby, M A, Ibrahim, N & Robert, C 2022, ' Antitumor activity of ipilimumab or BRAF ± MEK inhibition after pembrolizumab treatment in patients with advanced melanoma : analysis from KEYNOTE-006 ', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 33, no. 2, pp. 204-215 . https://doi.org/10.1016/j.annonc.2021.10.010Test

مصطلحات موضوعية: Proto-Oncogene Proteins B-raf, advanced melanoma, Oncology, BRAF inhibition, medicine.medical_specialty, Ipilimumab, Pembrolizumab, Antibodies, Monoclonal, Humanized, Internal medicine, medicine, Humans, In patient, ipilimumab, Melanoma, Complete response, Advanced melanoma, Mitogen-Activated Protein Kinase Kinases, Antitumor activity, Manchester Cancer Research Centre, business.industry, ResearchInstitutes_Networks_Beacons/mcrc, Hematology, medicine.disease, MEK inhibition, pembrolizumab, business, Progressive disease, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ae40264769d12ae7ca2fde50f109b8fTest
https://doi.org/10.1016/j.annonc.2021.10.010Test

المؤلفون: Christian U. Blank, B. Schermers, Sara H. Muller, A.C.J. van Akkooi, Annemarie Bruining, B.A. van de Wiel, Viola Franke, Carolien Bierman, W.J. van Houdt, Theo J.M. Ruers, B. ten Haken, Elisa A. Rozeman, Michel W.J.M. Wouters

المساهمون: Nanobiophysics, Magnetic Detection and Imaging, Technical Medicine

المصدر: The British Journal of Surgery
British journal of surgery, 106(5), 519-522. Wiley

مصطلحات موضوعية: Oncology, Male, medicine.medical_specialty, medicine.medical_treatment, UT-Hybrid-D, Pilot Projects, 030230 surgery, 03 medical and health sciences, Magnetics, 0302 clinical medicine, Antineoplastic Agents, Immunological, Internal medicine, Surgical removal, Medicine, Humans, Stage III melanoma, In patient, General, Rapid Research Communication, Lymph node, Melanoma, Neoadjuvant therapy, Neoplasm Staging, Ultrasonography, business.industry, Node (networking), Immunotherapy, Middle Aged, Ipilimumab, Neoadjuvant Therapy, Dissection, medicine.anatomical_structure, Nivolumab, Lymphatic Metastasis, Lymph Node Excision, Surgery, Female, Lymph Nodes, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e573d5fff633f1dd2bc58d6eb5e9d35Test
http://www.scopus.com/inward/record.url?scp=85063523883&partnerID=8YFLogxKTest

المؤلفون: Catriona M. McNeil, Christian U. Blank, Antoni Ribas, Jean-Jacques Grob, Matteo S. Carlino, Omid Hamid, Clemens Krepler, Michal Lotem, James Larkin, Caroline Robert, Teresa M. Petrella, Paul Lorigan, Laurent Mortier, Georgina V. Long, Erin Jensen, Jacob Schachter, Scott J. Diede, Bart Neyns, Ana Arance, Adil Daud

المساهمون: Medical Oncology, Clinical sciences, Laboratory of Molecular and Medical Oncology, Laboratory of Molecullar and Cellular Therapy

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, Ipilimumab, Pembrolizumab, 03 medical and health sciences, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, Long term survival, medicine, In patient, business, 030215 immunology, medicine.drug, Advanced melanoma

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2b58ea7696aac607a6b8b94623bd747Test
https://biblio.vub.ac.be/vubir/longterm-survival-from-pembrolizumab-pembro-completion-and-pembro-retreatment-phase-iii-keynote006-in-advanced-melanomaTest(06384d96-ea38-49d1-a40c-297993de00d7).html

المؤلفون: Christian U. Blank, Axel Bex, Roderick de Bruijn, John B. A. G. Haanen, Simon Horenblas, Teele Kuusk, Allard Noe, Kees Hendricksen

المساهمون: Urology, CCA - Cancer Treatment and quality of life

المصدر: Urology, 109, 127-132. Elsevier Inc.
de Bruijn, R E, Kuusk, T, Noe, A P, Blank, C U, Haanen, J B A G, Hendricksen, K, Horenblas, S & Bex, A 2017, ' Observation After Cytoreductive Nephrectomy in Patients With Synchronous Not Completely Resected Metastases of Renal Cell Carcinoma ', Urology, vol. 109, pp. 127-132 . https://doi.org/10.1016/j.urology.2017.06.048Test

مصطلحات موضوعية: medicine.medical_specialty, business.industry, Urology, medicine.medical_treatment, 030232 urology & nephrology, medicine.disease, Debulking, Systemic therapy, Surgery, Targeted therapy, Metastasis, Lesion, 03 medical and health sciences, 0302 clinical medicine, Renal cell carcinoma, Response Evaluation Criteria in Solid Tumors, 030220 oncology & carcinogenesis, Medicine, In patient, Radiology, medicine.symptom, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e6c3b5a21f56ecbf13034ba2002a2d8Test
https://doi.org/10.1016/j.urology.2017.06.048Test

المؤلفون: Michel W.J.M. Wouters, Alexander C.J. van Akkooi, Annegien Broeks, Christian U. Blank, Stephanie A. Blankenstein, Winan J. van Houdt, Judith M. Versluis, Petros Dimitriadis, Joyce Sanders, Yvonne Schrage, Willem Hoefakker

المصدر: Journal of Clinical Oncology. 39:9579-9579

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, medicine.medical_treatment, Systemic therapy, Clinical Practice, Internal medicine, medicine, Interferon gamma, Stage III melanoma, In patient, business, Value (mathematics), Adjuvant, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::ea4f85c6d1ff6b7d851803c0b14cdfc0Test
https://doi.org/10.1200/jco.2021.39.15_suppl.9579Test

المؤلفون: Christian U. Blank, Axel Bex, Mark M. Kockx, Yasmin Abu-Ghanem, Johannes V. Van Thienen, Peter A. van Dam, Brunolf W. Lagerveld, Thomas Powles, John B. A. G. Haanen, Niels M. Graafland, Patricia J. Zondervan, Harrie P. Beerlage, Jeroen van Moorselaar, Bernadett Szabados

المصدر: Journal of Clinical Oncology. 39:4573-4573

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, biology, business.industry, medicine.medical_treatment, medicine.disease, Nephrectomy, Axitinib, Avelumab, Vascular endothelial growth factor, chemistry.chemical_compound, chemistry, Renal cell carcinoma, Internal medicine, medicine, biology.protein, In patient, Antibody, business, Immune infiltrate, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::b3c57d7017264ab4a32bf84b6f669e4fTest
https://doi.org/10.1200/jco.2021.39.15_suppl.4573Test

المؤلفون: Anne M. Hendriks, Karijn P M Suijkerbuijk, Christian U. Blank, Alison Weppler, L. Brown, Judith M. Versluis, Adriana Hepner, Mathilde Jalving, Victoria Atkinson, Prachi Bhave, L. Storey, Ellen Kapiteijn, E.G.E. de Vries, J. Mangana, Douglas B. Johnson, Clara Allayous, Claudia Trojaniello, K. de Joode, Yanina J L Jansen, Lisa Zimmer

المصدر: Annals of Oncology. 31:S733-S734

مصطلحات موضوعية: Metastatic melanoma, business.industry, Melanoma, Hematology, medicine.disease, Immune checkpoint, Lesion, Single tumour, Oncology, Cancer research, medicine, In patient, medicine.symptom, business, Value (mathematics)

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::b671493029c6e915d751497f992a6a70Test
https://doi.org/10.1016/j.annonc.2020.08.1204Test

المؤلفون: Christian U. Blank, Scot Ebbinghaus, Reinhard Dummer, Carmen Loquai, Steven J. O'Day, Antoni Ribas, Adil Daud, Jacob Schachter, Caroline Robert, Janice M. Mehnert, Dirk Schadendorf, S. Peter Kang, Wei Zhou, Igor Puzanov, Darcy A. Hille, April K.S. Salama, Omid Hamid, Lee D. Cranmer, Alfons J.M. van den Eertwegh, Axel Hauschild

المساهمون: University of Zurich, Schadendorf, Dirk, Medical oncology, CCA - Clinical Therapy Development

المصدر: Schadendorf, D, Dummer, R, Hauschild, A, Robert, C, Hamid, O, Daud, A, van den Eertwegh, A, Cranmer, L, O'Day, S, Puzanov, I, Schachter, J, Blank, C, Salama, A, Loquai, C, Mehnert, J M, Hille, D, Ebbinghaus, S, Kang, S P, Zhou, W & Ribas, A 2016, ' Health-related quality of life in the randomised KEYNOTE-002 study of pembrolizumab versus chemotherapy in patients with ipilimumab-refractory melanoma ', European Journal of Cancer, vol. 67, pp. 46-54 . https://doi.org/10.1016/j.ejca.2016.07.018Test
European Journal of Cancer, 67, 46-54. Pergamon

مصطلحات موضوعية: Male, Cancer Research, Skin Neoplasms, Health Status, Health-related quality of life, medicine.medical_treatment, Medizin, Pembrolizumab, Carboplatin, 0302 clinical medicine, Quality of life, Antineoplastic Combined Chemotherapy Protocols, 1306 Cancer Research, 030212 general & internal medicine, Melanoma, Aged, 80 and over, 10177 Dermatology Clinic, Middle Aged, Advanced melanoma, Dacarbazine, Oncology, 030220 oncology & carcinogenesis, Female, 2730 Oncology, medicine.drug, Adult, KEYNOTE-002, medicine.medical_specialty, Adolescent, Paclitaxel, 610 Medicine & health, Ipilimumab, Antibodies, Monoclonal, Humanized, Disease-Free Survival, Young Adult, 03 medical and health sciences, Refractory, Internal medicine, Temozolomide, medicine, Humans, Chemotherapy, In patient, Patient Reported Outcome Measures, Aged, Patient-reported outcomes, business.industry, Cancer, EORTC QLQ-C30, medicine.disease, Surgery, Quality of Life, business, Ipilimumab-refractory melanoma

وصف الملف: 663_Schadendorf D. et al._Health-related quality of life in the randomised KEYNOTE-002_EJC 2016.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0340a48931fc5ff52f9246c04eeed519Test
https://doi.org/10.1016/j.ejca.2016.07.018Test

المؤلفون: Christian U. Blank, Sofie Wilgenhof, J.B.A.G. Haanen, Loes M. Pronk, Maartje W. Rohaan, J.H. van den Berg, B.A. van de Wiel, T.N. Schumacher, A. Sari, Ferry Lalezari, H. van Tinteren, Raquel Gomez-Eerland, H. Mallo, M. van Zon, Bastiaan Nuijen, J.V. van Thienen, M.H. Geukes Foppen, J. H. Beijnen, R. De Boer, Noor A. M. Bakker

المصدر: Annals of Oncology. 30:v481-v482

مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, Metastatic melanoma, business.industry, Stock options, Melan-A Protein, Hematology, Peripheral blood, Autologous T-cells, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Oncology, Cell dose, 030220 oncology & carcinogenesis, Maximum tolerated dose, Internal medicine, medicine, In patient, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::9b3374e4370635ab1a9b126103cb46e1Test
https://doi.org/10.1093/annonc/mdz253.010Test

المؤلفون: Christian U. Blank, J.B. Elbers, Stefan M. Willems, B. Tan, J.L. Vos, Xiaohang Qiao, Laura A. Smit, M.W.M. van den Brekel, B. Jasperse, L. Zuur, J.P. de Boer, Ton N. Schumacher, J.B.A.G. Haanen, Wouter V. Vogel, A. van der Leun, Abrahim Al-Mamgani, Oscar Krijgsman, Daniel S. Peeper

المصدر: Annals of Oncology. 31:S1169

مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Ipilimumab, Hematology, medicine.disease, Head and neck squamous-cell carcinoma, Internal medicine, Medicine, In patient, Nivolumab, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::1458c5fc3acbb26ab2db1d59da9f0c11Test
https://doi.org/10.1016/j.annonc.2020.08.2270Test